Skip to main content
    U

    Ultragenyx (RARE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $16.70
    +0.80 (+5.03%)

    Market Cap: $1.62B

    Last updated: Nov 17, 2026 at 4:37 PM ET

    Ultragenyx (RARE) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Ultragenyx (RARE) has a latest price of $16.70 on Nov 17, 2026, 58.1% below its 52-week high of $39.89. Its price fell 49.5% over the past 12 months. The month-end price fell 72.7% over the 10 years through Oct 2026, a compound annual decline of 12.2%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $141.54 in Feb 2021 and its lowest $15.03 in Sep 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart RARE with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RARE.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 36.4%, and over 6 months it fell 25.6%. The month-end price fell 54.5% over the 3 years through Oct 2026, a compound annual decline of 23.1%.

    PeriodChange
    1 month+10.8%
    3 months-36.4%
    6 months-25.6%
    12 months-49.5%
    12 months, with dividends-49.5%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-54.5%-23.1%
    5 years-80.8%-28.1%
    10 years-72.7%-12.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 224.1%, and its weakest was 2025, when it fell 45.3%.

    YearCloseChange
    2026 through Oct 2026$16.10-30.0%
    2025$23.00-45.3%
    2024$42.07-12.0%
    2023$47.82+3.2%
    2022$46.33-44.9%
    2021$84.09-39.3%
    2020$138.43+224.1%
    2019$42.71-1.8%
    2018$43.48-6.3%
    2017$46.38-34.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 8.9% above its 50-day average of $15.34 and 25.6% below its 200-day average of $22.45.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$16.70
    52-week high$39.89-58.1%
    52-week low$12.73+31.2%
    50-day average$15.34+8.9%
    200-day average$22.45-25.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 78.3%.

    MeasureValue
    1-year beta1.34
    Largest fall, 1 year-64.8%
    Largest fall, 3 years-78.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About RARE

    What is RARE's 1-year price change?

    Ultragenyx's price fell 49.5% over the past 12 months. With dividends included, the 12-month total return was -49.5%.

    What is RARE's 5-year price change?

    Ultragenyx's month-end price fell 80.8% over the 5 years through Oct 2026, a compound annual decline of 28.1%. These figures leave out dividends.

    What is RARE's 52-week high and low?

    Ultragenyx's 52-week high is $39.89 and its 52-week low is $12.73. Its latest price of $16.70 on Nov 17, 2026 is 58.1% below the high.

    What is RARE's beta?

    Ultragenyx's 1-year beta against the S&P 500 is 1.34, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 64.8%.

    Is the RARE chart free?

    Yes. Advanced Charting for RARE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.